In MASH-related HCC mouse models, the androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), combined with obesity-induced IL-6/STAT3 signaling, induces lipid metabolic reprogramming and MDSC-dominated immunosuppression [161]. Here, AR is linked to hepatocellular carcinoma.